Hutch News
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
T cells as biomarkers for hepatitis B disease prognosis
From the Newell lab, Vaccine and Infectious Disease Division
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more
HIV’s ever-evolving envelope
From the Bloom Laboratory (Basic Sciences Division)
Good News: Bricker resolution tips, vote for Open Science Prize, 425 Magazine salute to HIV research
Celebrating faculty and staff achievements
International AIDS Conference: Where we’ve been, what’s next in the quest to end HIV
The last time the International AIDS Conference was in Africa, AIDS denialism was at its height; two Fred Hutch leaders in the fight to end HIV talk about where we’ve been – and what’s next
‘Don’t stop now’: an endgame for HIV/AIDS
HBO’s ‘Countdown to Zero,’ featuring Fred Hutch researchers, shows the pandemic remains, but fresh hope abounds
Countdown to Zero: The path to an HIV vaccine
A World AIDS Day Q&A with Fred Hutch’s Dr. Larry Corey, featured in HBO special report
Growing a lab: How a young scientist makes leap from postdoc to principal investigator
A young scientist makes the leap from postdoc to principal investigator
Still here
Tacoma’s ‘Art AIDS America’ exhibit carries a message that HIV researchers, activists support
Good News at Fred Hutch
<p>CTI BioPharma and Fred Hutch announce international research fellowship in blood cancers; Dr. Julie Overbaugh receives $2.5M NIDA grant for HIV research; Dr. Johnnie Orozco wins grant to develop less-toxic cancer treatment; Dr. Philip Greenberg named editor-in-chief of Cancer Immunology Research; CFO Randy Main receives AIRI lifetime achievement award</p>
Good News at Fred Hutch
<p>Dr. Michele Andrasik honored for advocacy of women with HIV; Fred Hutch Web developers win digital marketing award</p>
HIV vaccine clinical trial launches in South Africa
Community plays key role in testing a modified version of ‘Thai vaccine’ regimen
Closing in on ‘holy grail’ of HIV vaccine
Researchers describe a way to induce long-sought broadly neutralizing antibodies
Glenda Gray: The HIV warrior
Researcher’s anti-apartheid activism prepared her to take on both AIDS and its deniers
Finding a better way to take a bite out of malaria’s power
Fred Hutch and collaborators launch new trials to infect – and quickly treat – volunteers to test experimental drugs
Having discovered HIV, Dr. Françoise Barré-Sinoussi wants a cure
Having discovered HIV, Dr. Françoise Barré-Sinoussi wants a cure
'His presence was always felt'
Fred Hutch’s Dr. Larry Corey honors pioneering HIV researcher Dr. Joep Lange
A baby ‘cured’ of HIV shows signs of virus
But other research to find a cure continues
Hoping out loud: After years of silence, talk of an HIV cure
After years of silence, talk of an HIV cure
'Rest in peace, Tata': South Africa mourns Nelson Mandela's death
Mandela, the country's first black president, was vocal about the clarity of science that unequivocally connected HIV with AIDS
HIV vaccine researcher Julie McElrath receives Women of Influence Award - Fred Hutchinson Cancer Research Center
She is among 16 recipients of annual award sponsored by Puget Sound Business Journal